Fibroblast Growth Factor Receptor (FGFR) Inhibitor Market

Key Players

• Bayer
• Blueprint Medicine Corporation
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb
• F. Hoffmann-La Roche Ag
• Incyte Corporation
• Novartis International AG
• The Vanguard Group